Skip to main content
. 2022 Jul 18;15(7):1095–1107. doi: 10.18240/ijo.2022.07.09

Table 3. Initial, final, and relative change in GCL, RNFL and VA for anti-MOG cohort.

Parameters 1 2 3 4 5 6 7 8 9 10 11 12 Average
GCL 65, 62, -3 84, 62, -12 85, 82, -3 83, 56, -26 61, 58, -3 76, 81, +5 34, 35, +1 73, 50, -23 80, 72, -8 54, 52, -2 79, 78, -1 33, 73, +40 67.23, 63.42, -2.92
RNFL 104, 60, -44 175, 88, -87 114, 91, -23 139, 57, -82 55, 55, 0 94, 92, -2 379, 86, -293 235, 47, -188 203, 80, -123 58, 58, 0 143, 110, -33 254, 84, 170 162.75, 75.67, -58.75
VA 1, 0, -1 1, 0.2, -0.8 0.1, 0.1, 0 1, 0.5, -0.5 2.1, 0.1, -2 0.3, 0.2, -0.1 2.1, 0, -2.1 1, 0.1, -0.9 0.2, 0, -0.2 0.5, 0.2, -0.3 0.5, 0, -0.5 0, 0.1, +0.1 0.82, 0.13, -0.66

GCL: Ganglion cell layer; RNFL: Retinal nerve fiber layer; VA: Visual acuity.

initial, final, change; µm